Summary: H.R.6717 — 115th Congress (2017-2018)All Information (Except Text)

There is one summary for H.R.6717. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (09/06/2018)

Depression Side Effect Labeling Awareness Act of 2018

This bill amends the Federal Food, Drug, and Cosmetic Act to require the label of a drug that has an increased risk of suicide or depression to prominently display such risk.